Latest News
The pharma giant is well-positioned to lead the $200 billion global obesity treatment market.
Via The Motley Fool · June 8, 2026
Explore five cheap Canadian stocks that remain overlooked and may offer strong long‑term upside as fundamentals improve.
Via The Motley Fool · June 8, 2026
But is this the best way to buy shares?
Via The Motley Fool · June 8, 2026
This top TSX stock has dropped significantly but has multiple growth catalysts that could spur a swift recovery in its share price.
Via The Motley Fool · June 8, 2026
Nvidia is going after a lucrative market that's currently dominated by AMD and Intel.
Via The Motley Fool · June 8, 2026
Enbridge stock currently has a strong dividend yield of almost 5%, with a business that's ready to meet the energy needs of the future.
Via The Motley Fool · June 8, 2026
This infrastructure builder just posted record numbers, yet the market is treating it like an afterthought.
Via The Motley Fool · June 8, 2026
Technically speaking, Bitcoin's floor is zero, but that's unlikely to happen if history is any guide.
Via The Motley Fool · June 8, 2026
Building a successful website requires more than just publishing high-quality content. Whether you run a blog, an online store, or a business website, help
Via Talk Markets · June 8, 2026
IntroductionFinding the perfect home is one of the most important decisions for any family. Homebuyers today look for spacious residences, premium amenitie
Via Talk Markets · June 8, 2026
Chemtrade’s monthly distribution has been climbing, and its cash-flow coverage suggests the payout isn’t just a headline.
Via The Motley Fool · June 8, 2026
One brand boasts a vast global reach, while the other delivers higher margins and faster growth. Explore how their fundamentals stack up for investors.
Via The Motley Fool · June 8, 2026
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion.
Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas
Via MarketBeat · June 8, 2026
The protein comstibles maker is on the wrong side of a stock index rebalancing.
Via The Motley Fool · June 8, 2026
These TSX dividend stocks are supported by fundamentally strong businesses, resilient earnings, and sustainable payouts.
Via The Motley Fool · June 8, 2026
CIBC (TSX:CM) shares are still cheap and could be a great buy to pull ahead of inflation.
Via The Motley Fool · June 8, 2026
A strong quarter and its first stock split as a public company weren't enough to satisfy a stock priced for perfection.
Via The Motley Fool · June 8, 2026
These IPOs are bringing a lot of capital into the crypto sector via a brand new route that could have a beneficial spillover effect.
Via The Motley Fool · June 8, 2026
It's floating a large-scale convertible notes issue.
Via The Motley Fool · June 8, 2026
Buffett is known for his focus on stocks' valuations.
Via The Motley Fool · June 8, 2026
Is Byrna Technologies a hidden gem in the stock market or a risky bet? Join us as we evaluate its business potential, management, and financial health in this insightful episode of Scoreboard.
Via The Motley Fool · June 8, 2026
Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT.
Mark Singleton, Bioventus’ senior vice president and chief financi
Via MarketBeat · June 8, 2026
Vail Resorts (NYSE:MTN) said historically poor weather across the Western United States continued to weigh on fiscal third-quarter results, pressuring visitation and revenue at its mountain resorts while management emphasized that its advance commitment pass model and cost controls helped cushion th
Via MarketBeat · June 8, 2026
Via Benzinga · June 8, 2026
A maxed TFSA can become a tax-free income engine, and these three dividend payers offer different ways to get there.
Via The Motley Fool · June 8, 2026